Market Tracker

04/17 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

11.61
Data as of Apr 17
 +1.33 / +12.94%
Today’s Change
3.80
Today|||52-Week Range
19.11
+43.69%
Year-to-Date

Today’s Trading

Previous close10.28
Today’s open10.25
Day’s range10.05 - 11.82
Volume564,960
Average volume (3 months)598,632
Market cap$268.0M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)-79.63%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book368.18

Competitors

 Today’s
change
Today’s
% change
TTHITransition Therapeut...+0.05+0.90%
VCYTVeracyte Inc-0.06-0.45%
GERNGeron Corp-0.03-1.52%
OXFDOxford Immunotec Glo...+0.11+0.62%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 16, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$9.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts